10701 related articles for article (PubMed ID: 1580557)
1. Expression of alpha-melanocyte stimulating hormone and the invasive ability of the B16 murine melanoma.
Zubair A; Lakshmi MS; Sherbet GV
Anticancer Res; 1992; 12(2):399-402. PubMed ID: 1580557
[TBL] [Abstract][Full Text] [Related]
2. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
3. Expression of the transmembrane glycoprotein CD44 and metastasis associated 18A2/MTS1 gene in B16 murine melanoma cells.
Lakshmi MS; Parker C; Sherbet GV
Anticancer Res; 1997; 17(5A):3451-5. PubMed ID: 9413186
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway.
Liu GS; Liu LF; Lin CJ; Tseng JC; Chuang MJ; Lam HC; Lee JK; Yang LC; Chan JH; Howng SL; Tai MH
Mol Pharmacol; 2006 Feb; 69(2):440-51. PubMed ID: 16269535
[TBL] [Abstract][Full Text] [Related]
5. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
Panasci LC; McQuillan A; Kaufman M
J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.
Bianchini F; D'Alessio S; Fibbi G; Del Rosso M; Calorini L
Oncol Rep; 2006 Mar; 15(3):709-14. PubMed ID: 16465434
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.
Miao Y; Hoffman TJ; Quinn TP
Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579
[TBL] [Abstract][Full Text] [Related]
9. Anti-cell death activity promotes pulmonary metastasis of melanoma cells.
Takaoka A; Adachi M; Okuda H; Sato S; Yawata A; Hinoda Y; Takayama S; Reed JC; Imai K
Oncogene; 1997 Jun; 14(24):2971-7. PubMed ID: 9205104
[TBL] [Abstract][Full Text] [Related]
10. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
[TBL] [Abstract][Full Text] [Related]
12. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.
Eberle AN; Froidevaux S
J Mol Recognit; 2003; 16(5):248-54. PubMed ID: 14523936
[TBL] [Abstract][Full Text] [Related]
15. Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone.
Murata J; Ayukawa K; Ogasawara M; Watanabe H; Saiki I
Int J Cancer; 1999 Mar; 80(6):889-95. PubMed ID: 10074923
[TBL] [Abstract][Full Text] [Related]
16. B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone.
Solca FF; Chluba-de Tapia J; Iwata K; Eberle AN
FEBS Lett; 1993 May; 322(2):177-80. PubMed ID: 8482388
[TBL] [Abstract][Full Text] [Related]
17. Immunological block to synthetic alpha-melanocyte-stimulating hormone: melanocyte interaction by antibodies isolated from cell-column immunoadsorbents.
Winkelhake JL; Elcombe BM; Hodach A
Cancer Res; 1979 Aug; 39(8):3058-64. PubMed ID: 455290
[TBL] [Abstract][Full Text] [Related]
18. Alpha-melanocyte-stimulating hormone stimulates protein kinase C activity in murine B16 melanoma.
Buffey J; Thody AJ; Bleehen SS; Mac Neil S
J Endocrinol; 1992 Jun; 133(3):333-40. PubMed ID: 1319452
[TBL] [Abstract][Full Text] [Related]
19. Metastasis-associated mts1 gene expression is down-regulated by heat shock in variant cell lines of the B16 murine melanoma.
Cajone F; Debiasi S; Parker C; Lakshmi MS; Sherbet GV
Melanoma Res; 1994 Jun; 4(3):143-50. PubMed ID: 7919958
[TBL] [Abstract][Full Text] [Related]
20. An improved imaging agent for malignant melanoma, based on [Nle4,D-Phe7]alpha-melanocyte stimulating hormone.
Bard DR
Nucl Med Commun; 1995 Oct; 16(10):860-6. PubMed ID: 8570117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
